This indicated that the diagnostic efficiency of PCT and CT may not decrease in early RA, whereas there could be a significant decline in the sensitivity of anti-CCP when diagnosing patients with early RA rather than patients with established RA [54]. This evidence concerns the gene CALCA and rheumatoid arthritis.